Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Libo Yao

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Cancer Biology & Therapy|March 10, 2017
Chronic inflammation confers to the metabolic reprogramming associated with tumorigenesis of colorectal cancerDingding Qu, Liangliang Shen, Shaoqing Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2013
Retrograde ductal administration of the adenovirus-mediated NDRG2 gene leads to improved sialaden hypofunction in estrogen-deficient ratsYan Li, Changhao Liu, Wugang Hou, et al.
Journal of Colloid and Interface Science|January 9, 2020
A vacuum impregnation method for synthesizing octahedral Pt<sub>2</sub>CuNi nanoparticles on mesoporous carbon support and the oxygen reduction reaction electrocatalytic propertiesDezhen Wu, Xiaochen Shen, Li Qin Zhou, et al.
Histochemistry and Cell Biology|January 4, 2011
Variation of NDRG2 and c-Myc expression in rat heart during the acute stage of ischemia/reperfusion injuryZhongchan Sun, Lan Shen, Xiang Sun, et al.
Plos One|May 1, 2013
Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathwayYan Guo, Ji Ma, Lin Wu, et al.
Cancer Research|May 20, 2017
Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung CancerMingxiang Ye, Yong Zhang, Xinxin Zhang, et al.
Journal of Cellular Biochemistry|February 5, 2015
Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinomaYan Guo, Qiao Pan, Jing Zhang, et al.
Oncology Letters|March 12, 2019
Effect of PTEN loss on metabolic reprogramming in prostate cancer cellsXin Zhou, Xu Yang, Xiang Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 29, 2016
Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary FibrosisHu Zhao, Huan Bian, Xin Bu, et al.
Oncotarget|August 29, 2015
Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expressionXinyuan Xu, Jianying Li, Xiang Sun, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Cancer Biology & Therapy|March 10, 2017
Chronic inflammation confers to the metabolic reprogramming associated with tumorigenesis of colorectal cancerDingding Qu, Liangliang Shen, Shaoqing Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2013
Retrograde ductal administration of the adenovirus-mediated NDRG2 gene leads to improved sialaden hypofunction in estrogen-deficient ratsYan Li, Changhao Liu, Wugang Hou, et al.
Journal of Colloid and Interface Science|January 9, 2020
A vacuum impregnation method for synthesizing octahedral Pt<sub>2</sub>CuNi nanoparticles on mesoporous carbon support and the oxygen reduction reaction electrocatalytic propertiesDezhen Wu, Xiaochen Shen, Li Qin Zhou, et al.
Histochemistry and Cell Biology|January 4, 2011
Variation of NDRG2 and c-Myc expression in rat heart during the acute stage of ischemia/reperfusion injuryZhongchan Sun, Lan Shen, Xiang Sun, et al.
Plos One|May 1, 2013
Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathwayYan Guo, Ji Ma, Lin Wu, et al.
Cancer Research|May 20, 2017
Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung CancerMingxiang Ye, Yong Zhang, Xinxin Zhang, et al.
Journal of Cellular Biochemistry|February 5, 2015
Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinomaYan Guo, Qiao Pan, Jing Zhang, et al.
Oncology Letters|March 12, 2019
Effect of PTEN loss on metabolic reprogramming in prostate cancer cellsXin Zhou, Xu Yang, Xiang Sun, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 29, 2016
Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary FibrosisHu Zhao, Huan Bian, Xin Bu, et al.
Oncotarget|August 29, 2015
Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expressionXinyuan Xu, Jianying Li, Xiang Sun, et al.
Pageof 14